A feasibility and safety study of afamelanotide in acute stroke patients – an open label, proof of concept, phase iia clinical trial.

Autor: Stanislaus, Vimal1,2 (AUTHOR), Kam, Anthony2 (AUTHOR), Murphy, Lily2 (AUTHOR), Wolgen, Philippe3 (AUTHOR), Walker, Gill3 (AUTHOR), Bilbao, Pilar3 (AUTHOR), Cloud, Geoffrey C1,2 (AUTHOR) G.Cloud@alfred.org.au
Zdroj: BMC Neurology. 7/26/2023, Vol. 23 Issue 1, p1-6. 6p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje